Growing community of inventors

Brooklyn, NY, United States of America

Felix Kopp

Average Co-Inventor Count = 4.61

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Felix KoppEvripidis Gavathiotis (3 patents)Felix KoppUlrich G Steidl (2 patents)Felix KoppDenis E Reyna (2 patents)Felix KoppSandhya Kortagere (1 patent)Felix KoppSridhar Mani (1 patent)Felix KoppRichard N Kitsis (1 patent)Felix KoppDulguun Amgalan (1 patent)Felix KoppLorrie Kirshenbaum (1 patent)Felix KoppThomas P Garner (1 patent)Felix KoppChamini Karunaratne (1 patent)Felix KoppZdenek Dvorak (1 patent)Felix KoppFelix Kopp (4 patents)Evripidis GavathiotisEvripidis Gavathiotis (17 patents)Ulrich G SteidlUlrich G Steidl (7 patents)Denis E ReynaDenis E Reyna (2 patents)Sandhya KortagereSandhya Kortagere (16 patents)Sridhar ManiSridhar Mani (8 patents)Richard N KitsisRichard N Kitsis (2 patents)Dulguun AmgalanDulguun Amgalan (1 patent)Lorrie KirshenbaumLorrie Kirshenbaum (1 patent)Thomas P GarnerThomas P Garner (1 patent)Chamini KarunaratneChamini Karunaratne (1 patent)Zdenek DvorakZdenek Dvorak (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Albert Einstein College of Medicine (4 from 504 patents)

2. Drexel University (1 from 604 patents)

3. The University of Manitoba (1 from 199 patents)

4. Palacky University Olomouc (1 from 4 patents)


4 patents:

1. 12016845 - BAX activators and uses thereof in cancer therapy

2. 11938128 - Small molecule BAX inhibitors and uses thereof

3. 11724998 - PXR agonists and uses thereof for gut barrier dysfunction treatment and prevention

4. 11382898 - BAX activators and uses thereof in cancer therapy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…